Biotech companies are a popular commodity on the IPO market
In July, the US biotech companies IPO market
demonstrated record growth
Weekly Pharmacy www.apteka.ua based on thepharmaletter: July a strong month for life sciences IPOs and M&AAccording to the financial company Burrill&Co. (Strong Demand and Performance for Life Sciences IPOs Continues in July), July was the busiest month on the Initial Public Offering (IPO) market on the stock exchange among American biotech companies for more than 13 years.
So, the IPO was conducted by 6 companies, 5 of which debuted on the US stock exchanges during the last week of July. In general, in the first 7 months of 2013, 29 companies attracted a total of USD 5 billion on the exchanges of this country. For comparison, in the same period of 2012, 11 companies raised $771 million.
Not even taking into account $2.6 billion. From the IPO of Zoetis (a split-off division of Pfizer), the biotech sector has been the most promising for IPOs since 2000. Steven Burrill, Executive director of Burrill & Co., says that for a long time most investors were not inclined to invest in the biotechnology industry due to the uncertainty noted in this area. Now, fueled by the success of clinical trials and high market indicators, investors, actively acquiring shares of companies, can shake up the market.
July also turned out to be productive in terms of mergers and acquisitions. Of the announced transactions in the amount of $ 15.5 billion, $ 13.2 billion. they were concluded in the last week.
"Perrigo" (manufacturer of over-the-counter drugs), announced plans to acquire "Elan" for $ 8.6 billion. After that, Perrigo is expected to move its headquarters from Michigan (USA) to Ireland, where the tax environment is more attractive.
Cubist Pharmaceuticals, also active in the field of mergers and acquisitions, announced its readiness to acquire Optimer Pharmaceuticals and Trius Therapeutics, each of which is valued at just over $800 million. Both companies are developing medicines to fight bacterial infections.
For 7 months of 2013, the global mergers and acquisitions market grew to $75.8 billion, which is 2.3% more than in the same period of 2012.
Portal "Eternal youth" http://vechnayamolodost.ru14.08.2013